deferoxamine has been researched along with Candida Infection in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigates the pathophysiology of mucormycosis caused by Rhizopus, which has been reported in 46 dialysis patients, while treated with deferoxamine (DFO)." | 7.68 | Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. ( Boelaert, JR; Cantinieaux, B; de Locht, M; Kerrels, V; Schneider, YJ; Van Cutsem, J; Van Landuyt, HW; Verdonck, A, 1993) |
| "This study investigates the pathophysiology of mucormycosis caused by Rhizopus, which has been reported in 46 dialysis patients, while treated with deferoxamine (DFO)." | 3.68 | Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. ( Boelaert, JR; Cantinieaux, B; de Locht, M; Kerrels, V; Schneider, YJ; Van Cutsem, J; Van Landuyt, HW; Verdonck, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boelaert, JR | 2 |
| de Locht, M | 1 |
| Van Cutsem, J | 1 |
| Kerrels, V | 1 |
| Cantinieaux, B | 1 |
| Verdonck, A | 1 |
| Van Landuyt, HW | 1 |
| Schneider, YJ | 1 |
| Mencacci, A | 1 |
| Cenci, E | 1 |
| Bucci, P | 1 |
| Mosci, P | 1 |
| Fè d'Ostiani, C | 1 |
| Bistoni, F | 1 |
| Romani, L | 1 |
2 other studies available for deferoxamine and Candida Infection
| Article | Year |
|---|---|
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.
Topics: Animals; Blood Physiological Phenomena; Candida albicans; Candidiasis; Deferoxamine; Guinea Pigs; Hu | 1993 |
Iron overload alters innate and T helper cell responses to Candida albicans in mice.
Topics: Animals; Candida albicans; Candidiasis; Cytokines; Deferoxamine; Disease Susceptibility; Ferric Comp | 1997 |